Advanced search
Publication Cover
Gynecological Endocrinology Volume 35, 2019 - Issue 11
Submit an article Journal homepage
129
Views
0
CrossRef citations to date
0
Altmetric
BREAST DENSITY CHANGES DURING HT WITH TRANSDERMAL ESTROGENS ALONE OR IN COMBINATION WITH PROGESTERONE

Changes in breast density during hormone treatment with transdermal estrogens alone or in combination with progesterone

Pascual Garcia-AlfaroDepartment of Obstetrics, Gynecology and Reproduction, Hospital Universitario Dexeus, Barcelona, SpainCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-1790-7752
ORCID Icon,
Ignacio RodríguezDepartment of Obstetrics, Gynecology and Reproduction, Hospital Universitario Dexeus, Barcelona, SpainORCID Iconhttp://orcid.org/0000-0002-6586-0111
ORCID Icon,
Francesc TresserraDepartment of Obstetrics, Gynecology and Reproduction, Hospital Universitario Dexeus, Barcelona, SpainORCID Iconhttp://orcid.org/0000-0003-4330-7603
ORCID Icon &
Jean L. BrowneDepartment of Obstetrics, Gynecology and Reproduction, Hospital Universitario Dexeus, Barcelona, SpainORCID Iconhttp://orcid.org/0000-0002-9241-941X
ORCID Icon
Pages 991-994 | Received 16 Jan 2019, Accepted 06 May 2019, Published online: 21 May 2019

References

  • Hickey M, Elliott J, Davison SL. Hormone replacement therapy. BMJ. 2012;344:e763.
  • de Villiers TJ, Gass ML, Haines CJ, et al. Global Consensus Statement on menopausal hormone therapy. Maturitas. 2013;74:391–392.
  • Maclennan AH, Broadbent JL, Lester S, et al. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2004;18:CD002978.
  • Rossouw JE, Anderson GL, Prentice RL, et al. Writing Group for the Women’s Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women’s health initiative randomize controlled trial. JAMA. 2002;288:321–333.
  • Beral V, Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003;362:419–427.
  • Wolfe JN. Breast patterns as an index of risk for developing breast cancer. AJR Am J Roentgenol. 1976;126:1130–1137.
  • Mc Cormack VA, dos Santos I. Breast density and parenchymal patterns as markers of breast cancer risk: a metaanalysis. Cancer Epidemiol Biomarkers Prev. 2006;15:1159–1169.
  • Rutter CM, Mandelson MT, Laya MB, et al. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA. 2001;285:171–176.
  • Boyd NF, Guo H, Martin L, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356:227–236.
  • Greendale GA, Reboussin BA, Sie A, et al. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med. 1999;130:262–269.
  • Lundström E, Wilczek B, von Palffy Z, et al. Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens. Climateric. 2001;4:42–48.
  • McTiernan A, Martin CF, Peck JD, et al. Estrogen-plus-progestin use and mammographic density in postmenopausal women: women’s health Initiative randomized trial. J Natl Cancer Inst. 2005;97:1366–1376.
  • Topal NB, Ayhan S, Topal U, et al. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins. J Obstet Gynaecol Res. 2006;32:305–308.
  • Couto E, Qureshi SA, Hofvind S, et al. Hormone therapy use and mammographic density in postmenopausal Norwegian women. Breast Cancer Res Treat. 2012;132:297–305.
  • Brand JS, Czene K, Shepherd JA, et al. Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment. Cancer. Epidemiol Biomarkers Prev. 2014;23:1764–1772.
  • Huo CW, Chew GL, Britt KL, et al. Mammographic density-a review on the current understanding of its association with breast cancer. Breast Cancer Res Treat. 2014;144:479–502.
  • Shepherd JA, Kerlikowske K, Ma L, et al. Volume of mammographic density and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:1473–1482.
  • Sacchetto D, Morra L, Agliozzo S, et al. Mammographic density: comparison of visual assessment with fully automatic calculation on a multivendor dataset. Eur Radiol. 2016;26:175–183.
  • Johansson H, von Tiedemann M, Erhard K, et al. Breast-density measurement using photon-counting spectral mammography. Med Phys. 2017;44:3579–3593.
  • Greendale GA, Reboussin BA, Slone S, et al. Postmenopausal hormone therapy and change in mammagraphic density. J Natl Cancer Inst. 2003;95:30–37.
  • Byrne C, Ursin G, Martin CF, et al. Mammographic density change with estrogens and progestin therapy and breast cancer risk. J Natl Cancer Inst. 2017;109. doi:10.1093/jnci/djx001.
  • Azam S, Lange T, Huynh S, et al. Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study. Cancer Causes Control. 2018;29:495–505.
  • Murkes D, Lalitkumar PG, Leifland K, et al. Percutaneous estradiol/oral micronized progesterone has less-adverse effects and different gene regulations than oral conjugated equine estrogens/medroxyprogesterone acetate in the breasts of healthy women in vivo. Gynecol Endocrinol. 2012;28(2):12–15.
  • L’Hermite M. Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal. Climacteric. 2017;20:331–338.
  • Stute P, Wildt L, Neulen J. The impact of micronized progesterone on breast cancer risk: a systematic review. Climacteric. 2018;21:111–122.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.